To Evaluate the Phase I Clinical Study of JSKN016 in Chinese Patients With Advanced Malignant Solid Tumors

Clinical trial NCT06592417 · RECRUITING

Trial details

NCT number: NCT06592417
Sponsor: Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Malignant Solid Tumor

Start date: 2024-04-30
Primary completion: 2026-05-17
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.